Literature DB >> 23446256

Non-apoptotic effects of antiapoptotic agent zVAD-fmk in renal injury.

Gur P Kaushal, Sudhir V Shah.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23446256      PMCID： PMC4080714          DOI： 10.1038/ki.2012.470

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  4 in total

Review 1.  Apoptosis and acute kidney injury.

Authors:  Andrea Havasi; Steven C Borkan
Journal:  Kidney Int       Date:  2011-05-11       Impact factor: 10.612

Review 2.  Caspase inhibitors promote alternative cell death pathways.

Authors:  Peter Vandenabeele; Tom Vanden Berghe; Nele Festjens
Journal:  Sci STKE       Date:  2006-10-24

3.  zVAD-fmk prevents cisplatin-induced cleavage of autophagy proteins but impairs autophagic flux and worsens renal function.

Authors:  Christian Herzog; Cheng Yang; Alexandrea Holmes; Gur P Kaushal
Journal:  Am J Physiol Renal Physiol       Date:  2012-08-15

4.  Rip1 (receptor-interacting protein kinase 1) mediates necroptosis and contributes to renal ischemia/reperfusion injury.

Authors:  Andreas Linkermann; Jan H Bräsen; Nina Himmerkus; Shuya Liu; Tobias B Huber; Ulrich Kunzendorf; Stefan Krautwald
Journal:  Kidney Int       Date:  2012-01-11       Impact factor: 10.612
  4 in total
  3 in total

1.  Combined treatment with low concentrations of decitabine and SAHA causes cell death in leukemic cell lines but not in normal peripheral blood lymphocytes.

Authors:  Barbora Brodská; Aleš Holoubek; Petra Otevřelová; Kateřina Kuželová
Journal:  Biomed Res Int       Date:  2013-08-13       Impact factor: 3.411

Review 2.  Autophagy Function and Regulation in Kidney Disease.

Authors:  Gur P Kaushal; Kiran Chandrashekar; Luis A Juncos; Sudhir V Shah
Journal:  Biomolecules       Date:  2020-01-07

Review 3.  Metabolic Flexibility and Innate Immunity in Renal Ischemia Reperfusion Injury: The Fine Balance Between Adaptive Repair and Tissue Degeneration.

Authors:  Alessandra Tammaro; Jesper Kers; Angelique M L Scantlebery; Sandrine Florquin
Journal:  Front Immunol       Date:  2020-07-07       Impact factor: 7.561
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.